[1] 原发性肝癌诊疗规范(2019年版). 中国临床医学,2020,27: 140-160.
[2] Chen C, Yang H, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA,2006,295: 65-73.
[3] Chen G, Lin W, Shen F, et al. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol, 2006,101: 1797-1803.
[4] Hosaka T, Suzuki F, Kobayashi M, et al. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology, 2013,58: 98-107.
[5] 王贵强, 段钟平, 王福生, 等.慢性乙型肝炎防治指南(2019年版). 实用肝脏病杂志, 2020,23: 9-32.
[6] 魏来, 段钟平, 王贵强. 丙型肝炎防治指南(2019年版). 实用肝脏病杂志, 2020,23: 33-52.
[7] 酒精性肝病防治指南(2018年更新版). 实用肝脏病杂志, 2018,21: 170-176.
[8] 陈成伟, 成军, 窦晓光,等. 原发性胆汁性肝硬化(又名原发性胆汁性胆管炎)诊断和治疗共识(2015年). 临床肝胆病杂志, 2015,31: 1980-1988.
[9] 自身免疫性肝炎诊断和治疗共识(2015年). 临床肝胆病杂志, 2016,32: 9-22.
[10] 徐小元, 丁惠国, 李文刚,等. 肝硬化诊治指南. 实用肝脏病杂志, 2019,22: 770-786.
[11] Wang JH, Changchien CS, Hu TH, et al. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients. Eur J Cancer, 2008,44: 1000-1006. |